Literature DB >> 27039722

HOXA9 is Underexpressed in Cervical Cancer Cells and its Restoration Decreases Proliferation, Migration and Expression of Epithelial-to-Mesenchymal Transition Genes.

Liliana Alvarado-Ruiz1, Maria Guadalupe Martinez-Silva, Luis Alberto Torres-Reyes, Patricia Pina-Sanchez, Pablo Ortiz-Lazareno, Alejandro Bravo-Cuellar, Adriana Aguilar-Lemarroy, Luis Felipe Jave-Suarez.   

Abstract

HOX transcription factors are evolutionarily conserved in many different species and are involved in important cellular processes such as morphogenesis, differentiation, and proliferation. They have also recently been implicated in carcinogenesis, but their precise role in cancer, especially in cervical cancer (CC), remains unclear. In this work, using microarray assays followed by the quantitative polymerase chain reaction (qPCR), we found that the expression of 25 HOX genes was downregulated in CC derived cell lines compared with nontumorigenic keratinocytes. In particular, the expression of HOXA9 was observed as down-modulated in CCderived cell lines. The expression of HOXA9 has not been previously reported in CC, or in normal keratinocytes of the cervix. We found that normal CC from women without cervical lesions express HOXA9; in contrast, CC cell lines and samples of biopsies from women with CC showed significantly diminished HOXA9 expression. Furthermore, we found that methylation at the first exon of HOXA9 could play an important role in modulating the expression of this gene. Exogenous restoration of HOXA9 expression in CC cell lines decreased cell proliferation and migration, and induced an epithelial-like phenotype. Interestingly, the silencing of human papilloma virus (HPV) E6 and E7 oncogenes induced expression of HOXA9. In conclusion, controlling HOXA9 expression appears to be a necessary step during CC development. Further studies are needed to delineate the role of HOXA9 during malignant progression and to afford more insights into the relationship between downmodulation of HOXA9 and viral HPV oncoprotein expression during cercical cancer development.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27039722     DOI: 10.7314/apjcp.2016.17.3.1037

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  13 in total

1.  Re-expression of pro-fibrotic, embryonic preserved mediators in irradiated arterial vessels of the head and neck region.

Authors:  Patrick Möbius; Raimund H M Preidl; Manuel Weber; Kerstin Amann; Friedrich W Neukam; Falk Wehrhan
Journal:  Strahlenther Onkol       Date:  2017-08-15       Impact factor: 3.621

2.  Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion.

Authors:  Seong-Lan Yu; Han Koo; Hoi Young Lee; Young Il Yeom; Dong Chul Lee; Jaeku Kang
Journal:  Cell Oncol (Dordr)       Date:  2019-01-29       Impact factor: 6.730

3.  Circular RNA circFADS2 inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-766-3p/HOXA9 axis.

Authors:  Zhang Zhang; Huijun Sun; Junzhi Hou; Lili Li; Lijuan Wu
Journal:  Histol Histopathol       Date:  2021-12-16       Impact factor: 2.303

4.  Upregulated expression of HOXC8 is associated with poor prognosis of cervical cancer.

Authors:  Yuxiu Huang; Lihong Chen; Aqin Guo
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

5.  MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.

Authors:  Kai Wang; Jun Jin; Tengxiao Ma; Hongfeng Zhai
Journal:  J Cell Mol Med       Date:  2017-08-05       Impact factor: 5.310

6.  Upregulated HOXA9 expression is associated with lymph node metastasis in colorectal cancer.

Authors:  Yohei Watanabe; Motonobu Saito; Katsuharu Saito; Yoshiko Matsumoto; Yasuyuki Kanke; Hisashi Onozawa; Suguru Hayase; Wataru Sakamoto; Teruhide Ishigame; Tomoyuki Momma; Shinji Ohki; Seiichi Takenoshita
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

7.  Biomarkers in Tumorigenesis Using Cancer Cell Lines: A Systematic Review

Authors:  Lizbeth Raju K; Dominic Augustine; Roopa S Rao; Sowmya S V; Vanishri C Haragannavar; Shwetha Nambiar; Kavitha Prasad; Kamran Habib Awan; Shankargouda Patil
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

8.  The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.

Authors:  Chongchang Zhou; Jinyun Li; Qun Li; Huigao Liu; Dong Ye; Zhenhua Wu; Zhisen Shen; Hongxia Deng
Journal:  J Clin Lab Anal       Date:  2019-03-06       Impact factor: 2.352

9.  Transcription Factor HOXA9 is Linked to the Calcification and Invasion of Papillary Thyroid Carcinoma.

Authors:  Yilan Jin; Hyeung Kyoo Kim; Jeonghun Lee; Euy Young Soh; Jang-Hee Kim; Insun Song; Yoon-Sok Chung; Yong Jun Choi
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

10.  HIF-1α or HOTTIP/CTCF Promotes Head and Neck Squamous Cell Carcinoma Progression and Drug Resistance by Targeting HOXA9.

Authors:  Qiang Sun; Shuai-Yuan Zhang; Jun-Fang Zhao; Xin-Guang Han; Hai-Bin Wang; Ming-Lei Sun
Journal:  Mol Ther Nucleic Acids       Date:  2020-02-14       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.